(Received for publication February 8, 1988) Aculeacin A and echinocandin B are cyclopeptide antibiotics with a long-chain fatty acid (palmitic acid and linoleic acid, respectively1 '"45) that are active against some yeasts and a few filamentous fungi4~9 Photomicrographs of untreated wild-type hyphae (A) and within the zone of inhibition by LY121019 (B). Note hyphae (h) and branch point (b). Bar in A represents 150 /urn while bar in B represents 100pm. Photomicrographs of regenerating os-l protoplasts untreated (A) and within the zone of inhibition by LY121019 (B). Note primary protoplast (p), hyphae (h) and abnormal hyphae (ah). Bar in A represents 200 /^m while bar in B is 40^m. and LY121019 are reported to inhibit a number of yeasts and a few filamentous fungi4»5>7~12'16>24). To determine the effects of these compounds on N. crassa, both germinating macroconidia of wild-type and regenerating protoplasts of os-l were embedded in agar and disks containing these drugs placed on the surface. These results are summarized in Table 1 , and show that all four antifungal compounds inhibit N. crassa (wild-type and os-l). When cells within zones of inhibition were examined by light microscopy, they were found to have altered hyphal morphologies: Fig. 1A shows untreated wild-type; note the long, sparsely branched hyphae. Fig.   IB shows an LY121019-inhibited wild-type colony; note that the hyphae are irregularly shaped and that branching is greater than in untreated controls. Regenerating protoplasts of os-l were also inhibited by LY121019 (Fig. 2) . Note the aberrant hyphae that regenerated within the zone of inhibition.
Clearly, LY121019 inhibits N. crassa growth resulting in morphologically abnormal hyphae. LY1 21019 Inhibits N. crassa a-3V£-D-Glucan
Synthase Activity
The effect of LY121019 on (l-3)-/3-D-glucan synthase activity present in crude lysates of wildtype protoplasts is shown in Fig. 3A ; the double reciprocal replot is presented in Fig. 3B Taken together, our data are consistent with the idea that LY121019 inhibits fungal growth by inhibiting (l-3)-/3-D-glucan synthase in vivo.
Definitive proof of this hypothesis awaits the isolation of LY121019-resistant mutants and the demonstration that (l-3)-/5-D-glucan synthase is resistant to inhibition by LY121019in vitro. A search for these mutants is presently underway.
